Triple-dose regimen may permanently clear HIV in infected newborns
Six outlets today report on a triple-dose regimen that may permanently clear HIV in newborns
Evidence dossier
Intelligence passport
Measured timeline
- Detected The first matching coverage entered the Archynetys cluster.
- Latest coverage observed Most recent article currently attached to this story cluster.
- Peak measured velocity The recorded velocity reached 4.
- Evidence threshold reached The story had enough independent coverage for an explanatory brief.
Source diversity sample: IAVI · Scientific Frontline · Inside Precision Medicine · The Lund Report · nature.com · Medical Xpress.
How this dossier is built: methodology · AI policy · corrections.
Quick answers
What is the ENABLE project?
The ENABLE project is an initiative launched by IAVI to evaluate the enhancement of HIV treatment in infants by adding monoclonal antibodies to existing regimens.
What does the triple-dose regimen consist of?
The triple-dose regimen consists of antiretroviral therapy, broadly neutralizing antibodies, and CCR5 blockade.
What did the OHSU study find?
The OHSU study found that a three-pronged treatment approach cleared HIV in infants.
The brief
Six outlets today report on a triple-dose regimen that may permanently clear HIV in newborns. The treatment could revolutionize HIV management in infants, offering a potential cure rather than lifelong treatment. The regimen combines antiretroviral therapy, broadly neutralizing antibodies, and CCR5 blockade.
The ENABLE project, launched by IAVI, aims to evaluate this enhanced treatment. A study by Oregon Health & Science University (OHSU) found that the three-pronged approach cleared HIV in infants. Research published on nature.com used an infant macaque model to demonstrate that the combination therapy limits viral reservoir seeding.
The open question is whether this regimen will translate to human infants with the same success.
Synthesized by Archynetys from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 27m ago.
The reporting (6)
- ENABLE project launches to evaluate the enhancement of treatment of HIV in infants by adding monoclonal antibodies IAVI · 1d ago
- Triple-Dose Regimen May Clear HIV in Newborns Scientific Frontline · 1d ago
- Early Research Suggests Triple Therapy Could Clear HIV in Newborns Inside Precision Medicine · 1d ago
- OHSU Study: New, three-pronged treatment clears HIV in infants The Lund Report · 1d ago
- Combination therapy with broadly neutralizing antibodies, antiretroviral therapy and CCR5 blockade limits viral reservoir seeding in infant macaque model of HIV nature.com · 1d ago
- Triple-dose regimen may permanently clear HIV in infected newborns Medical Xpress · 1d ago
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
Topics
Related trends
How poor countries are dealing with America’s AIDS cuts
Global health systems face a reconfiguration of HIV response strategies following an adjustment to United States aid policy.
A Beaver County man is part of a clinical trial for a brain implant that collapses the time usually needed between surgery and radiation - Pittsburgh Post-Gazette
A new brain implant technology is redefining postoperative radiation treatment for brain metastases by reducing the time between surgery and radiation.
1,700 H.I.V. Treatment Sites Closed After Trump Aid Cuts, a Study Finds
A new study reveals that 1,700 HIV treatment sites have closed following aid cuts implemented by the Trump administration.
Open prediction lab
Can you beat the machine?
Pick tomorrow's top trend, then compare your result with Archynetys's self-graded forecast.
📬 The daily trend digest
The world's top trends, once a day. No spam, one-click unsubscribe.